These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Cross-reactive and mono-reactive SARS-CoV-2 CD4+ T cells in prepandemic and COVID-19 convalescent individuals. Johansson AM; Malhotra U; Kim YG; Gomez R; Krist MP; Wald A; Koelle DM; Kwok WW PLoS Pathog; 2021 Dec; 17(12):e1010203. PubMed ID: 34965282 [TBL] [Abstract][Full Text] [Related]
5. Immunopeptidome profiling of human coronavirus OC43-infected cells identifies CD4 T cell epitopes specific to seasonal coronaviruses or cross-reactive with SARS-CoV-2. Becerra-Artiles A; Nanaware PP; Muneeruddin K; Weaver GC; Shaffer SA; Calvo-Calle JM; Stern LJ bioRxiv; 2022 Dec; ():. PubMed ID: 36482973 [TBL] [Abstract][Full Text] [Related]
6. Immunogenic T cell epitopes of SARS-CoV-2 are recognized by circulating memory and naïve CD8 T cells of unexposed individuals. Quiros-Fernandez I; Poorebrahim M; Fakhr E; Cid-Arregui A EBioMedicine; 2021 Oct; 72():103610. PubMed ID: 34627082 [TBL] [Abstract][Full Text] [Related]
7. Cross-Recognition of SARS-CoV-2 B-Cell Epitopes with Other Betacoronavirus Nucleoproteins. Tajuelo A; López-Siles M; Más V; Pérez-Romero P; Aguado JM; Briz V; McConnell MJ; Martín-Galiano AJ; López D Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328398 [TBL] [Abstract][Full Text] [Related]
8. Healthy donor T cell responses to common cold coronaviruses and SARS-CoV-2. Woldemeskel BA; Kwaa AK; Garliss CC; Laeyendecker O; Ray SC; Blankson JN J Clin Invest; 2020 Dec; 130(12):6631-6638. PubMed ID: 32966269 [TBL] [Abstract][Full Text] [Related]
9. Potential CD8+ T Cell Cross-Reactivity Against SARS-CoV-2 Conferred by Other Coronavirus Strains. Lee CH; Pinho MP; Buckley PR; Woodhouse IB; Ogg G; Simmons A; Napolitani G; Koohy H Front Immunol; 2020; 11():579480. PubMed ID: 33250893 [TBL] [Abstract][Full Text] [Related]
10. Limited Recognition of Highly Conserved Regions of SARS-CoV-2. Swaminathan S; Lineburg KE; Ambalathingal GR; Crooks P; Grant EJ; Mohan SV; Raju J; Panikkar A; Le Texier L; Tong ZWM; Chew KY; Neller MA; Short KR; Gowda H; Gras S; Khanna R; Smith C Microbiol Spectr; 2022 Feb; 10(1):e0278021. PubMed ID: 35196796 [TBL] [Abstract][Full Text] [Related]
11. COVID-19 coronavirus vaccine T cell epitope prediction analysis based on distributions of HLA class I loci (HLA-A, -B, -C) across global populations. Cun Y; Li C; Shi L; Sun M; Dai S; Sun L; Shi L; Yao Y Hum Vaccin Immunother; 2021 Apr; 17(4):1097-1108. PubMed ID: 33175614 [TBL] [Abstract][Full Text] [Related]
12. Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans. Mateus J; Grifoni A; Tarke A; Sidney J; Ramirez SI; Dan JM; Burger ZC; Rawlings SA; Smith DM; Phillips E; Mallal S; Lammers M; Rubiro P; Quiambao L; Sutherland A; Yu ED; da Silva Antunes R; Greenbaum J; Frazier A; Markmann AJ; Premkumar L; de Silva A; Peters B; Crotty S; Sette A; Weiskopf D Science; 2020 Oct; 370(6512):89-94. PubMed ID: 32753554 [TBL] [Abstract][Full Text] [Related]
13. A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection. Augusto DG; Murdolo LD; Chatzileontiadou DSM; Sabatino JJ; Yusufali T; Peyser ND; Butcher X; Kizer K; Guthrie K; Murray VW; Pae V; Sarvadhavabhatla S; Beltran F; Gill GS; Lynch KL; Yun C; Maguire CT; Peluso MJ; Hoh R; Henrich TJ; Deeks SG; Davidson M; Lu S; Goldberg SA; Kelly JD; Martin JN; Vierra-Green CA; Spellman SR; Langton DJ; Dewar-Oldis MJ; Smith C; Barnard PJ; Lee S; Marcus GM; Olgin JE; Pletcher MJ; Maiers M; Gras S; Hollenbach JA Nature; 2023 Aug; 620(7972):128-136. PubMed ID: 37468623 [TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 specific memory T cell epitopes identified in COVID-19-recovered subjects. Zhao J; Wang L; Schank M; Dang X; Lu Z; Cao D; Khanal S; Nguyen LN; Nguyen LNT; Zhang J; Zhang Y; Adkins JL; Baird EM; Wu XY; Ning S; Gazzar ME; Moorman JP; Yao ZQ Virus Res; 2021 Oct; 304():198508. PubMed ID: 34329696 [TBL] [Abstract][Full Text] [Related]
18. Screening HLA-A-restricted T cell epitopes of SARS-CoV-2 and the induction of CD8 Jin X; Ding Y; Sun S; Wang X; Zhou Z; Liu X; Li M; Chen X; Shen A; Wu Y; Liu B; Zhang J; Li J; Yang Y; Qiu H; Shen C; He Y; Zhao G Cell Mol Immunol; 2021 Dec; 18(12):2588-2608. PubMed ID: 34728796 [TBL] [Abstract][Full Text] [Related]
19. CD8 Qiu C; Xiao C; Wang Z; Zhu G; Mao L; Chen X; Gao L; Deng J; Su J; Su H; Fang EF; Zhang ZJ; Zhang J; Xie C; Yuan J; Luo OJ; Huang LA; Wang P; Chen G Front Immunol; 2021; 12():764949. PubMed ID: 35116022 [TBL] [Abstract][Full Text] [Related]
20. Identification of HLA-A*24:02-Restricted CTL Candidate Epitopes Derived from the Nonstructural Polyprotein 1a of SARS-CoV-2 and Analysis of Their Conservation Using the Mutation Database of SARS-CoV-2 Variants. Takagi A; Matsui M Microbiol Spectr; 2021 Dec; 9(3):e0165921. PubMed ID: 34937174 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]